HEPATITIS
NEWS The top stories compiled
from over 5,500 sources, updated every 15 minutes
China's Hepatitis B Virus Drug Market Will Grow to $800 Million by 2012
Competition From Chinese Makers Present Considerable Challenge to Branded Western Drug Companies Seeking to Penetrate Market, According to a New Report From Decision Resources WALTHAM, Mass., August 28, 2008 /PRNewswire/ -- Decision Resources, one of the
State urges clinic's patients to be tested for hepatitis C
LAURINBURG A nuclear stress test involves injecting a radioactive substance into the bloodstream as a way to check for inadequate blood flow in the heart. A recent investigation of the clinic revealed that unsafe medical practices could have been used
Hep C Treatment: Comparing the Pegylated Interferons
Learn about the facts on pegylated interferon alfa-2a and pegylated interferon alfa-2b, the standard treatment for chronic Hepatitis C. Comparing and contrasting the pegylated interferons may help better explain a physician’s preference or indifference between the two when treating their...
Silymarin Improves Quality of Life During Hepatitis C Treatment
Although a large-scale study concluded long-term interferon therapy to be ineffectual for Hepatitis C management, it demonstrated improvements in quality of life for participants supplementing with silymarin....
Cost-Effectiveness of Ultrasound-Guided Liver Biopsy
Fig. 1. Decision tree used to evaluate the cost-effectiveness of ultrasound-guided
liver biopsies
Information at this website is for educational purposes
only; statements about products and health conditions
have not been evaluated by the U.S. Food & Drug Administration.